Literature DB >> 154121

The role of the fibrinolytic system in thromboembolism.

J G Vermylen, D A Chamone.   

Abstract

The present concept of physiologic fibrinolysis was reviewed. It was concluded that the nonspecific proteolytic activity of plasmin would essentially be limited to fibrin in vivo in view of (A) the specific adsorption of activator and of plasminogen onto the fibrin surface resulting in local generation of plasmin and (B) the fact that plasmin, adsorbed to fibrin (in contrast to plasmin in the fluid phase) largely escapes from the action of antiplasmin. The hemostatic balance in the resting condition was discussed. It was concluded that under normal conditions, systemic intravascular fibrin deposition or formation must be either nonexistent or extremely limited. On the other hand, there is considerable evidence that a limited systemic fibrinogenolysis is going on in healthy individuals and that this process can be accelerated by simple physiologic procedures, such as strenuous physical exercise.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 154121     DOI: 10.1016/0033-0620(79)90013-6

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  6 in total

1.  Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack.

Authors:  H Kiesewetter; F Jung; E M Jung; C Mroweitz; J Koscielny; E Wenzel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 2.  Coagulative interventions during angiography.

Authors:  J J Bookstein; K M Moser; C Hougie
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

3.  Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile.

Authors:  R Sawaya; R F Highsmith
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

4.  Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

Authors:  R Sawaya; P Glas-Greenwalt
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

5.  Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

Authors:  J Aznar; A Estellés; G Tormo; P Sapena; V Tormo; S Blanch; F España
Journal:  Br Heart J       Date:  1988-05

6.  [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct].

Authors:  C Baumgartner; K Huber; F Holzner; K Zeiler; E Auff; B R Binder
Journal:  Klin Wochenschr       Date:  1988-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.